Provention Bio, a Sanofi Company
Global R&D-driven biopharmaceutical company focused on discovery, development and delivery of medicines and vaccines. Described as "AI-powered," the organization operates clinical development programs, vaccine and biologics manufacturing and distribution, patient access and advocacy initiatives, and a U.S. compliance and regulatory program.
Industries
N/A
Nr. of Employees
medium (51-250)
Provention Bio, a Sanofi Company
350 Water Street, Cambridge, United States
Products
Prescription medicines and biologics
Portfolio of prescription pharmaceuticals and biologic therapies across multiple therapeutic areas including immunology, oncology, neurology, diabetes, cardiovascular and rare diseases.
Vaccines
Preventive vaccines across multiple indications, supported by commercial launch and immunization programs.
Prescription medicines and biologics
Portfolio of prescription pharmaceuticals and biologic therapies across multiple therapeutic areas including immunology, oncology, neurology, diabetes, cardiovascular and rare diseases.
Vaccines
Preventive vaccines across multiple indications, supported by commercial launch and immunization programs.
Services
Evidence-based, unbiased medical information for healthcare professionals via a dedicated medical information website and contact channels.
Phone and web-based customer service for questions about prescription products and programs in the U.S.
Support channel for over-the-counter product questions via a customer portal and phone number.
Dedicated customer support line and online resources for vaccines-related inquiries and orders.
Access and support programs intended to improve patient access to medicines and related assistance resources.
Grant application and sponsorship processes for educational and community programs.
Evidence-based, unbiased medical information for healthcare professionals via a dedicated medical information website and contact channels.
Phone and web-based customer service for questions about prescription products and programs in the U.S.
Support channel for over-the-counter product questions via a customer portal and phone number.
Dedicated customer support line and online resources for vaccines-related inquiries and orders.
Access and support programs intended to improve patient access to medicines and related assistance resources.
Grant application and sponsorship processes for educational and community programs.
Expertise Areas
- Clinical trial management
- Vaccines development and commercial launch
- Biologics and therapeutic protein development
- Pharmacovigilance and medical information
Key Technologies
- mRNA platform research
- AI-driven analytics
- Biologics manufacturing
- Vaccine production technologies
News & Updates
Management reviewed third quarter 2025 results during a live audio webcast with the financial community.
Analysis of the 2024/2025 influenza season’s impact on health systems and considerations for effective protection.
Article discussing disease burden and therapeutic approaches in hemophilia.
Publication outlining company pricing principles and commitments to transparency and access.
Management reviewed third quarter 2025 results during a live audio webcast with the financial community.
Analysis of the 2024/2025 influenza season’s impact on health systems and considerations for effective protection.
Article discussing disease burden and therapeutic approaches in hemophilia.
Publication outlining company pricing principles and commitments to transparency and access.